ÀúÀ§Çèµµ Àü¸³¼±¾ÏÀÇ Ä¡·á
The Treatments for Low-Risk Prostate Cancer
ÀÌÁ¤¿ì, Á¤À翵, Á¶ÀÎâ, ±è¼ºÇÑ, ±ÇÈÖ¾È, Ãֹ̿µ, ¿©Á¤±Õ,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÁ¤¿ì ( Lee Jeong-Woo )
µ¿±¹´ëÇб³ Àϻ꺴¿ø ºñ´¢±â°ú
Á¤À翵 ( Jeong Jae-Young )
±¹¸³¾Ï¼¾ÅÍ ºñ´¢±â¾Ï¼¾ÅÍ
Á¶ÀÎâ ( Cho In-Chang )
±¹¸³°æÂûº´¿ø ºñ´¢±â°ú
±è¼ºÇÑ ( Kim Sung-Han )
±¹¸³¾Ï¼¾ÅÍ ºñ´¢±â¾Ï¼¾ÅÍ
±ÇÈÖ¾È ( Kwon Whi-An )
¸íÁöº´¿ø ºñ´¢±â°ú
Ãֹ̿µ ( Choi Mi-Young )
Çѱ¹º¸°ÇÀǷῬ±¸¿ø
¿©Á¤±Õ ( Yeo Jeong-Kyun )
ÀÎÁ¦´ëÇб³ ¼¿ï¹éº´¿ø ºñ´¢±â°ú
Abstract
Recently, the prevalence of prostate cancer has been increased with the screening of prostate-specific antigen and the increase in the elderly population. In particular, the diagnosis of the low-risk prostate cancer has increased greatly, and social interest for overtreatment has been heightened in Korea. Therefore, this review aimed to provide evidence-based treatment guidelines in low-risk prostate cancer based on Korean population. The literature provides evidence on treatment options, such as watchful waiting, active surveillance, radical prostatectomy, and radiation therapy according to the life expectancy of patients with low-risk prostate cancer. Furthermore, this review provides information on the efficacy of pelvic lymph node dissection and adjuvant radiation therapy during/after radical prostatectomy in low-risk prostate cancer.
Å°¿öµå
Prostatic neoplasms; Treatment-related cancers; Evidence-based medicine
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸